Pulmonx Corporation
LUNG | NASDAQ
$2.06
+$0.07 (+3.52%)
At close: Sep 22, 2026, 4:00 PM ET
$2.06
$0 (0.00%)
After-hours:
Sep 22, 2026, 7:30 PM ET
Market Data
Market Cap $84.05M
Enterprise Value $84.42M
Beta 0.28
Average Volume 554.93K
Shares Outstanding (Diluted) 42.18M
Shares Change YoY 4.95%
Institutional Ownership 75.89%
Exchange NASDAQ
ISIN US7458481014
Price Performance
Price Change 1M -11.6%
Price Change 3M 55.5%
Price Change 6M 53.1%
Price Change YTD -13.5%
Price Change 1Y 8.2%
Price Change 3Y -80.7%
Price Change 5Y -94.9%
1M CAGR (ann.) -2.5%
1Y CAGR (ann.) 24.4%
5Y CAGR (ann.) -44.6%
All-Time CAGR -39.3%
Valuation
PE Ratio -1.73
Forward PE N/A
PEG Ratio -0.08
Forward PEG 0.23
PS Ratio 0.96
Forward PS 0.90
PB Ratio 2.14
P/FCF Ratio -3.30
P/Adj. FCF Ratio -2.45
P/OCF Ratio -2.76
EV/Sales 0.97
EV/EBIT -1.93
EV/EBITDA -1.96
EV/FCF -3.32
Earnings Yield -57.8%
FCF Yield -30.3%
Adj. FCF Yield -40.8%
Financial Health
Net Debt $368K
Total Debt $56.21M
Cash & Short-Term Investments $55.84M
Total Assets $114.73M
Current Ratio 4.32
Quick Ratio 3.52
Debt / Equity Ratio 1.43
Debt / EBITDA -1.31
Debt / FCF -2.21
OCF / Debt -0.45
Interest Coverage -12.29
Altman Z-Score -5.77
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 77.1%
Operating Profit Margin -53.0%
EBITDA Margin -49.2%
Net Profit Margin -55.0%
FCF Margin -29.1%
Adj. FCF Margin -39.3%
SBC / Revenue 10.1%
SBC Impact (per share) -34.8%
Returns
Return on Assets -41.9%
Return on Equity -96.7%
Return on Invested Capital -48.4%
Return on Capital Employed -49.1%
Return on Tangible Assets -42.8%
Historical Growth (CAGR)
Revenue CAGR 3Y 13.0%
Revenue CAGR 5Y 15.9%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 12.9%
EPS CAGR 5Y 5.5%
EPS CAGR 10Y N/A
FCF CAGR 3Y 17.3%
FCF CAGR 5Y 14.6%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 9
EPS Growth Next 3Y 18.0%
Revenue Growth Next 3Y 12.1%
Earnings Date Nov 10, 2026
EPS Estimate (next Q) -$0.26
EPS Growth Est (next Q) -23.5%
Revenue Est (next Q) $21.93M
Revenue Growth Est (next Q) 2.0%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $10
Price Target Upside 402.5%
Cash Flow
Operating Cash Flow $-25.34M
Free Cash Flow $-25.45M
Adj. Free Cash Flow $-34.32M
FCF Per Share -$0.73
OCF Per Share -$0.72
OCF/S Ratio -34.9%
Income Statement
Revenue $87.44M
Gross Profit $67.38M
Operating Income $-46.31M
EBITDA $-43.05M
Net Income $-48.12M
EPS (Diluted) -$1.15
Revenue / Employee $295.41K
Profit / Employee $-162.55K
Employees 296
Add to Watchlist
Select watchlists to add or remove LUNG